| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | -0.025 | 0.4 |
| mRNA | Z-LLNle-CHO | GDSC1000 | pan-cancer | AAC | -0.039 | 0.5 |
| mRNA | semagacestat | CTRPv2 | pan-cancer | AAC | -0.029 | 0.5 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | -0.037 | 0.5 |
| mRNA | RAF265 | CTRPv2 | pan-cancer | AAC | 0.032 | 0.5 |
| mRNA | VX-680 | GDSC1000 | pan-cancer | AAC | 0.042 | 0.5 |
| mRNA | ZM-447439 | GDSC1000 | pan-cancer | AAC | 0.028 | 0.5 |
| mRNA | AZD6482 | CTRPv2 | pan-cancer | AAC | -0.028 | 0.5 |
| mRNA | LY317615 | GDSC1000 | pan-cancer | AAC | -0.026 | 0.5 |
| mRNA | BRD-K55116708 | CTRPv2 | pan-cancer | AAC | -0.028 | 0.5 |